SCHEMBL7985539

SCHEMBL7985539

CCc1nc(=O)c2c(ncn2CCCOc2ccccc2)[nH]1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 4/20 0.52
LMNA P02545 4/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
MAPT P10636 2/20 0.40
MPO P05164 1/20 0.40
TP53 P04637 1/20 0.40
HTT P42858 1/20 0.40
POLB P06746 3/20 0.39
KMT2A Q03164 3/20 0.39
RAB9A P51151 2/20 0.39
NPC1 O15118 1/20 0.39
MITF O75030 1/20 0.39
PKM P14618 1/20 0.39
MEN1 O00255 1/20 0.38
MAPK1 P28482 2/20 0.38
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985775 0.94 CNOT7 (0.58) CNOT7LMNAL3MBTL1POLBKMT2A
SCHEMBL7974538 0.82 CNOT7 (0.57) CNOT7LMNATSHRHTTPOLB
SCHEMBL7985534 0.82 L3MBTL1 (0.44) CNOT7LMNASMN1; SMN2ALOX15TSHR
SCHEMBL7975254 0.80 CNOT7 (0.55) CNOT7SMN1; SMN2POLBKMT2A
SCHEMBL7985450 0.78 CNOT7 (0.48) CNOT7LMNASMN1; SMN2ALOX15TSHR
SCHEMBL7987237 0.77 CNOT7 (0.57) CNOT7LMNATSHRPOLBMAPK1
SCHEMBL7985770 0.76 CNOT7 (0.50) CNOT7LMNASMN1; SMN2ALOX15TSHR
SCHEMBL7973938 0.76 CNOT7 (0.48) CNOT7SMN1; SMN2L3MBTL1TP53KMT2A
SCHEMBL7984516 0.75 TP53 (0.53) LMNAMAPTTP53
SCHEMBL7985085 0.74 CNOT7 (0.56) CNOT7LMNATSHRPOLBMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed